These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22265860)

  • 1. Recombinant protein vaccines produced in insect cells.
    Cox MM
    Vaccine; 2012 Feb; 30(10):1759-66. PubMed ID: 22265860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of cell culture-based influenza vaccine production.
    Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
    Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
    Buckland B; Boulanger R; Fino M; Srivastava I; Holtz K; Khramtsov N; McPherson C; Meghrous J; Kubera P; Cox MM
    Vaccine; 2014 Sep; 32(42):5496-502. PubMed ID: 25131727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture.
    Kis Z; Shattock R; Shah N; Kontoravdi C
    Biotechnol J; 2019 Jan; 14(1):e1800376. PubMed ID: 30537361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.
    Yamaji H
    Appl Microbiol Biotechnol; 2014 Mar; 98(5):1963-70. PubMed ID: 24407451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioprocessing of baculovirus vectors: a review.
    Aucoin MG; Mena JA; Kamen AA
    Curr Gene Ther; 2010 Jun; 10(3):174-86. PubMed ID: 20380645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a recombinant antibody fragment in whole insect larvae.
    O'Connell KP; Kovaleva E; Campbell JH; Anderson PE; Brown SG; Davis DC; Valdes JJ; Welch RW; Bentley WE; van Beek NA
    Mol Biotechnol; 2007 May; 36(1):44-51. PubMed ID: 17827537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a scaled-down aerobic fermentation model for scale-up in recombinant protein vaccine manufacturing.
    Farrell P; Sun J; Gao M; Sun H; Pattara B; Zeiser A; D'Amore T
    Vaccine; 2012 Aug; 30(38):5695-8. PubMed ID: 22633869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baculovirus as a vaccine vector.
    Lu HY; Chen YH; Liu HJ
    Bioengineered; 2012; 3(5):271-4. PubMed ID: 22705893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insect cells as hosts for the expression of recombinant glycoproteins.
    Altmann F; Staudacher E; Wilson IB; März L
    Glycoconj J; 1999 Feb; 16(2):109-23. PubMed ID: 10612411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture.
    Power J; Greenfield PF; Nielsen L; Reid S
    Cytotechnology; 1992; 9(1-3):149-55. PubMed ID: 1369168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing.
    Trombetta CM; Marchi S; Montomoli E
    Expert Rev Vaccines; 2022 Sep; 21(9):1233-1242. PubMed ID: 35678205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Sequeira DP; Correia R; Carrondo MJT; Roldão A; Teixeira AP; Alves PM
    Vaccine; 2018 May; 36(22):3112-3123. PubMed ID: 28291648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baculovirus as Versatile Vectors for Protein Display and Biotechnological Applications.
    Tsai CH; Wei SC; Lo HR; Chao YC
    Curr Issues Mol Biol; 2020; 34():231-256. PubMed ID: 31167963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insect Larvae: A New Platform to Produce Commercial Recombinant Proteins.
    Targovnik AM; Arregui MB; Bracco LF; Urtasun N; Baieli MF; Segura MM; Simonella MA; Fogar M; Wolman FJ; Cascone O; Miranda MV
    Curr Pharm Biotechnol; 2016; 17(5):431-8. PubMed ID: 26956108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
    Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Japanese encephalitis virus-like particles in insect cells.
    Yamaji H; Konishi E
    Bioengineered; 2013; 4(6):438-42. PubMed ID: 23639981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Herbert JA; Kay EJ; Faustini SE; Richter A; Abouelhadid S; Cuccui J; Wren B; Mitchell TJ
    Vaccine; 2018 Jun; 36(26):3809-3819. PubMed ID: 29778517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity and cost of vaccine manufacturing - An overview.
    Plotkin S; Robinson JM; Cunningham G; Iqbal R; Larsen S
    Vaccine; 2017 Jul; 35(33):4064-4071. PubMed ID: 28647170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
    López-Macías C
    Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.